结肠镜腺瘤检出试验的设计:串联研究比平行研究更易获得阳性结果——对影像技术与机械装置研究的分析
该研究系统检索了比较新型影像技术和机械装置的随机试验,纳入24项以腺瘤漏检率(AMR)为主要结局的串联研究和42项以腺瘤检出率(ADR)为主要结局的平行研究。串联研究中66.7%显示新方法显著优于对照,而平行研究仅23.8%;随机效应模型显示串联研究的绝对风险差约为平行研究的两倍。作者建议仅当串联研究的阳性结果同时得到平行试验阳性结果支持时才接受。
要点
- 串联研究阳性率66.7%(8222例),平行研究仅23.8%(28059例)。
- 机械装置阳性研究比例高于影像方法。
- 串联研究中94.2%的漏检腺瘤为小腺瘤(<1 cm)和/或非进展期。
核心结论
- 串联研究比简单平行试验更易获得阳性结果,可能源于参数、定义和方法学差异,也可能与偏倚可能性更高有关。
- 作者建议仅当串联研究的阳性结果同时伴有平行试验的阳性结果时才接受该阳性结果。
研究设计与样本
- 系统文献检索随机试验(全文、英文),纳入以腺瘤漏检率(AMR)或腺瘤检出率(ADR)为主要结局的串联或平行研究,评估新型影像技术和机械装置。
- 共纳入24项随机串联试验(以AMR为主要结局,定义和方法学不一)和42项平行研究(以ADR为主要结局,方法学同质)。
主要发现
- 串联研究中66.7%(8222例患者)显示新方法显著优于对照,平行研究仅23.8%(28059例患者)显示显著差异。
- 机械装置的阳性研究比例高于影像方法。
- 随机效应模型中,串联研究相比平行研究的绝对风险差约翻倍:影像方法串联0.04(0.01,0.07) vs 平行0.02(0.00,0.04);机械装置串联0.08(0.00,0.15) vs 平行0.04(0.01,0.07)。
- 串联研究中94.2%的漏检腺瘤为小腺瘤(<1 cm)和/或非进展期。
关键数值与推荐
- 串联研究阳性率66.7%(8222例患者) vs 平行研究23.8%(28059例患者)。
- 影像方法绝对风险差:串联0.04(0.01,0.07) vs 平行0.02(0.00,0.04)。
- 机械装置绝对风险差:串联0.08(0.00,0.15) vs 平行0.04(0.01,0.07)。
- 串联研究中94.2%的漏检腺瘤为小腺瘤(<1 cm)和/或非进展期。
临床怎么用
- 作者建议仅当串联研究的阳性结果同时伴有平行试验的阳性结果时才接受该阳性结果。
局限性
- 串联试验的AMR定义和方法学不一。
- 串联研究可能比平行试验有更高的偏倚可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Adenoma detection rate (ADR) has been shown to correlate with interval cancers after screening colonoscopy and is commonly used as surrogate parameter for its outcome quality. ADR improvements by various techniques have been studied in randomised trials using either parallel or tandem methodololgy. METHODS: A systematic literature search was done on randomised trials (full papers, English language) on tandem or parallel studies using either adenoma miss rates (AMR) or ADR as main outcome to test different novel technologies on imaging (new endoscope generation, narrow band imaging, iScan, Fujinon intelligent chromoendoscopy/blue laser imaging and wide angle scopes) and mechanical devices (transparent caps, endocuff, endorings and balloons). Available meta analyses were also screened for randomised studies. RESULTS: Overall, 24 randomised tandem trials with AMR (variable definitions and methodology) and 42 parallel studies using ADR (homogeneous methodology) as primary outcome were included. Significant differences in favour of the new method were found in 66.7% of tandem studies (8222 patients) but in only 23.8% of parallel studies (28 059 patients), with higher rates of positive studies for mechanical devices than for imaging methods. In a random-effects model, small absolute risk differences were found, but these were double in magnitude for tandem as compared with parallel studies (imaging: tandem 0.04 (0.01, 0.07), parallel 0.02 (0.00, 0.04); mechanical devices: tandem 0.08 (0.00, 0.15), parallel 0.04 (0.01, 0.07)). Nevertheless, 94.2% of missed adenomas in the tandem studies were small (<1 cm) and/or non-advanced. CONCLUSIONS: A tandem study is more likely to yield positive results than a simple parallel trial; this may be due to the use of different parameters, variable definitions and methodology, and perhaps also a higher likelihood of bias. Therefore, we suggest to accept positive results of tandem studies only if accompanied by positive results from parallel trials.
引用
- Zimmermann-Fraedrich K, Pohl H, Rösch T, et al. Designs of colonoscopic adenoma detection trials: more positive results with tandem than with parallel studies - an analysis of studies on imaging techniques and mechanical devices. Gut. 2020. PMID: 32409588. doi:10.1136/gutjnl-2020-320984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。